Abiomed expects FDA nod for Impella sooner than forecast

Abiomed said today that it expects the FDA to grant the pre-market approval application for its flagship Impella heart pump sooner rather than later, pushing up the timeline to March 2015.

Food & Drug Administration (FDA), Abiomed Inc.

News Well, MassDevice.com Earnings Roundup, 2014, Cardiac Assist Devices, Pre-Market Approval (PMA), Q2, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/UNDdbW